COMPANY
CND Life Sciences
Funding and NIH signals
- SEC Form D raise Raised $6.32M in debt securities (Form D filed Jun 16, 2026; amended Aug 3, 2026). SEC Form D 0001841099-26-000001 (Jun 16, 2026)
Evidence (1 event)
- Jun 16, 2026 · SEC Form D 0001841099-26-000001
Name of Issuer: CND Life Sciences, Inc.; CIK: 1841099; Address: Scottsdale, AZ; Submission type: D; Filing date: 2026-06-16; Industry Group: Biotechnology; Date of First Sale: 2026-06-09; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 6250000; Total Amount Sold: 4314750; Federal exemptions: 06b || Name of Issuer: CND Life Sciences, Inc.; CIK: 1841099; Address: Scottsdale, AZ; Submission type: D/A; Filing date: 2026-08-03; Industry Group: Biotechnology; Date of First Sale: 2026-06-09; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 6316514; Total Amount Sold: 6316514; Federal exemptions: 06b
- Jun 16, 2026 · SEC Form D 0001841099-26-000001
- NIH award NIH awarded $1.01M (SBIR Phase II 5R44NS143486-02, continuation, notice Sep 7, 2026). NIH RePORTER 5R44NS143486-02 (Sep 7, 2026)
Evidence (1 event)
- Sep 7, 2026 · NIH RePORTER 5R44NS143486-02
Organization: CND LIFE SCIENCES, INC.; City/State: Scottsdale, AZ; Project number: 5R44NS143486-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 1012800; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Analysis of Cutaneous Phosphorylated alpha-Synuclein to Identify Patients at Risk of Progressing from Essential Tremor to Parkinson's Disease; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 5R44NS143486-02
Timeline
- Grant Government grant — SBIR: $1.01M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.28M (annual award, as published), announced Aug 27, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Funding
NIH awards 7
- NIH award 5R44NS127696-03 FY2024: $954,862 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. Cutaneous Phosphorylated Alpha-Synuclein f source ↗
- NIH award 5R44NS127696-02 FY2023: $952,525 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. Cutaneous Phosphorylated Alpha-Synuclein f source ↗
- NIH award 5R44AG076072-02 FY2023: $1,168,467 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. A Diagnostic Test for Dementia with Lewy source ↗
- NIH award 1R44NS127696-01 FY2022: $1,092,613 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. Cutaneous Phosphorylated Alpha-Synuclein source ↗
- NIH award 1R44AG076072-01 FY2022: $1,239,804 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. A Diagnostic Test for Dementia with Lewy source ↗
- NIH award 5R44NS117214-02 FY2021: $1,198,087 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. PHS 2019-02 Omnibus Solicitation of the source ↗
- NIH award 1R44NS117214-01A1 FY2020: $1,214,227 awarded for that fiscal year; activity R44 (SBIR); PI LEVINE, TODD; recipient as written: CND LIFE SCIENCES, INC., Scottsdale, AZ. PHS 2019-02 Omnibus Solicitation of th source ↗